Definium Therapeutics (DFTX) Earnings Date, Estimates & Call Transcripts $22.50 0.00 (0.00%) As of 05/22/2026 04:00 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Definium Therapeutics Earnings Summary Definium Therapeutics announced Q1 2026 earnings on May 8, 2026, reporting an EPS of -$0.71, which missed the consensus estimate of -$0.48 by $0.23. With a trailing EPS of -$2.49, Definium Therapeutics' earnings are expected to grow next year, from ($2.26) to ($1.85) per share. Latest Q1 Earnings DateMay. 8EstimatedConsensus EPS (May. 8) -$0.48 Actual EPS (May. 8) -$0.71 Missed By -$0.23 Q1 2026 Earnings ResourcesQ1 2026 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q)Powered by Get Definium Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Definium Therapeutics and other key companies, straight to your inbox. Sign Up View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Estimated and Actual Earnings DataDFTX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Definium Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20262-$0.57-$0.46-$0.52Q2 20262-$0.55-$0.51-$0.53Q3 20262-$0.51-$0.46-$0.49Q4 20262-$0.55-$0.42-$0.49 FY 2026 8 -$2.18 -$1.85 -$2.02 Q1 20271-$0.41-$0.41-$0.41Q2 20271-$0.36-$0.36-$0.36Q3 20271-$0.35-$0.35-$0.35Q4 20271-$0.11-$0.11-$0.11 Definium Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails5/8/2026Q1 2026-$0.4780-$0.71 -$0.2320-$0.71--11/6/2025Q3 2025-$0.52-$0.78 -$0.26-$0.78--7/31/2025Q2 2025-$0.38-$0.50 -$0.12-$0.50--5/8/2025Q1 2025-$0.36-$0.35+$0.01-$0.35--3/6/2025Q4 2024-$0.33-$0.41 -$0.08-$0.41--11/7/2024Q3 2024-$0.29-$0.27+$0.02-$0.27--8/13/2024Q2 2024-$0.30-$0.48 -$0.18-$0.70-- Data powered by Fiscal.ai. Definium Therapeutics Earnings - Frequently Asked Questions When did Definium Therapeutics announce their last quarterly earnings? Definium Therapeutics (NASDAQ:DFTX) last announced its quarterly earning data on Friday, May 8, 2026. Learn more on DFTX's earnings history. Did Definium Therapeutics beat their earnings estimates last quarter? In the previous quarter, Definium Therapeutics (NASDAQ:DFTX) missed the analysts' consensus estimate of ($0.48) by $0.23 with a reported earnings per share (EPS) of ($0.71). Learn more on analysts' earnings estimate vs. DFTX's actual earnings. How can I listen to Definium Therapeutics' earnings conference call? The conference call for Definium Therapeutics' latest earnings report can be listened to online. Listen to Conference Call How can I read Definium Therapeutics' conference call transcript? The conference call transcript for Definium Therapeutics' latest earnings report can be read online. Read Transcript How much profit does Definium Therapeutics generate each year? Definium Therapeutics (NASDAQ:DFTX) has a recorded net income of -$183.79 million. DFTX has generated -$2.49 earnings per share over the last four quarters. What is Definium Therapeutics' EPS forecast for next year? Definium Therapeutics' earnings are expected to grow from ($2.26) per share to ($1.85) per share in the next year. More Earnings Resources from MarketBeat Related Companies Celcuity Earnings Date PACS Group Earnings Date Hims & Hers Health Earnings Date Sotera Health Earnings Date RadNet Earnings Date Caris Life Sciences Earnings Date Billiontoone Earnings Date Concentra Group Holdings Parent Earnings Date Veracyte Earnings Date Option Care Health Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Ross Stores Earnings Beat Sends Stock To New HighsWas Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus?Workday Validates AI Flywheel: Stock Price Recovery BeginsApparel Earnings Winners and Losers: Ralph Lauren Takes OffWhy Walmart, Target and TJX Got Such Different Reactions After EarningsThe Careful Consumer: What Q1 Earnings Reveal—And Where Cracks May AppearOverextended, e.l.f. Beauty Is Primed to Rebound in Back Half This page (NASDAQ:DFTX) was last updated on 5/25/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredRead now. Do not delete. You’ve been warned.Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” P...Porter & Company | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Definium Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Definium Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
